Canopy Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Canopy Biosciences's estimated annual revenue is currently $13.5M per year.
- Canopy Biosciences's estimated revenue per employee is $155,000
- Canopy Biosciences's total funding is $4.4M.
Employee Data
- Canopy Biosciences has 87 Employees.
- Canopy Biosciences grew their employee count by 58% last year.
Canopy Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $69.9M | 451 | 8% | N/A | N/A |
#2 | $0.9M | 6 | -14% | N/A | N/A |
#3 | $6.2M | 40 | -32% | N/A | N/A |
#4 | $0.9M | 6 | -14% | N/A | N/A |
#5 | $4.2M | 27 | -7% | N/A | N/A |
#6 | $0.9M | 6 | -45% | N/A | N/A |
#7 | $4.8M | 31 | 11% | N/A | N/A |
#8 | $3.4M | 22 | -15% | N/A | N/A |
#9 | $0.4M | 5 | 25% | N/A | N/A |
#10 | $4.3M | 28 | 65% | N/A | N/A |
What Is Canopy Biosciences?
Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing key technologies in the fields of genetic engineering and personalized medicine. Founded in 2016, Canopy has offices and laboratories in St. Louis, MO.
keywords:N/A$4.4M
Total Funding
87
Number of Employees
$13.5M
Revenue (est)
58%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Canopy Biosciences News
Canopy Biosciences' CellScape is the latest generation ChipCytometry instrument, which enables high-plex spatial imaging and quantification...
Canopy Biosciences' CellScape is the latest generation ChipCytometry TM instrument, which enables high-plex spatial imaging and...
Canopy Biosciences is headquartered in St. Louis, Missouri, with a CLIA site in California, and a site in Germany to serve researchers at...
Canopy Biosciences, a St. Louis, MO-based provider of gene editing and gene expression products and services, acquired Zellkraftwerk GmbH, a Leipzig, Germany-based multiplex cytometry company. Concurrent with the acquisition, Canopy closed a strategic growth investment from Ampersand Capital Pa ...
Canopy Biosciences, a St. Louis-based life sciences company, closed a $2.4m Series A financing. BioGenerator, the investment arm of BioSTL, and Kingdom Capital co-led the round, which saw participation from The Missouri Technology Corporation (MTC), PinPoint Holdings, Greenleaf Fund, and Arch A ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.7M | 87 | 9% | N/A |
#2 | $12.6M | 87 | 24% | N/A |
#3 | $25.2M | 87 | 16% | N/A |
#4 | $23.8M | 88 | 29% | N/A |
#5 | $7.5M | 89 | 2% | N/A |